Medical Care
Global mRNA Therapy Market Research Report 2025
- Jul 08, 25
- ID: 349122
- Pages: 84
- Figures: 84
- Views: 12
The global market for mRNA Therapy was valued at US$ 44900 million in the year 2024 and is projected to reach a revised size of US$ 105710 million by 2031, growing at a CAGR of 13.2% during the forecast period.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Therapy.
The mRNA Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Translate Bio
Regeneron Pharmaceuticals
Arcturus Therapeutics
Takeda Pharmaceutical Company
Novartis
Sanofi
Segment by Type
Vaccine
Drugs
Segment by Application
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Therapy.
The mRNA Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Translate Bio
Regeneron Pharmaceuticals
Arcturus Therapeutics
Takeda Pharmaceutical Company
Novartis
Sanofi
Segment by Type
Vaccine
Drugs
Segment by Application
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 mRNA Targeted Delivery in vivo
1.3.3 Genetically Modified T cells
1.3.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
1.3.5 Small Molecule Drugs Discovery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Therapy Market Perspective (2020-2031)
2.2 Global mRNA Therapy Growth Trends by Region
2.2.1 Global mRNA Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 mRNA Therapy Historic Market Size by Region (2020-2025)
2.2.3 mRNA Therapy Forecasted Market Size by Region (2026-2031)
2.3 mRNA Therapy Market Dynamics
2.3.1 mRNA Therapy Industry Trends
2.3.2 mRNA Therapy Market Drivers
2.3.3 mRNA Therapy Market Challenges
2.3.4 mRNA Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Therapy Players by Revenue
3.1.1 Global Top mRNA Therapy Players by Revenue (2020-2025)
3.1.2 Global mRNA Therapy Revenue Market Share by Players (2020-2025)
3.2 Global mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Therapy Revenue
3.4 Global mRNA Therapy Market Concentration Ratio
3.4.1 Global mRNA Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Therapy Revenue in 2024
3.5 Global Key Players of mRNA Therapy Head office and Area Served
3.6 Global Key Players of mRNA Therapy, Product and Application
3.7 Global Key Players of mRNA Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Therapy Breakdown Data by Type
4.1 Global mRNA Therapy Historic Market Size by Type (2020-2025)
4.2 Global mRNA Therapy Forecasted Market Size by Type (2026-2031)
5 mRNA Therapy Breakdown Data by Application
5.1 Global mRNA Therapy Historic Market Size by Application (2020-2025)
5.2 Global mRNA Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America mRNA Therapy Market Size (2020-2031)
6.2 North America mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America mRNA Therapy Market Size by Country (2020-2025)
6.4 North America mRNA Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Therapy Market Size (2020-2031)
7.2 Europe mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe mRNA Therapy Market Size by Country (2020-2025)
7.4 Europe mRNA Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Therapy Market Size (2020-2031)
8.2 Asia-Pacific mRNA Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific mRNA Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific mRNA Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Therapy Market Size (2020-2031)
9.2 Latin America mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America mRNA Therapy Market Size by Country (2020-2025)
9.4 Latin America mRNA Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Therapy Market Size (2020-2031)
10.2 Middle East & Africa mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa mRNA Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa mRNA Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Details
11.1.2 Moderna Business Overview
11.1.3 Moderna mRNA Therapy Introduction
11.1.4 Moderna Revenue in mRNA Therapy Business (2020-2025)
11.1.5 Moderna Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech mRNA Therapy Introduction
11.2.4 BioNTech Revenue in mRNA Therapy Business (2020-2025)
11.2.5 BioNTech Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer mRNA Therapy Introduction
11.3.4 Pfizer Revenue in mRNA Therapy Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Arcturus Therapeutics Holdings Inc.
11.4.1 Arcturus Therapeutics Holdings Inc. Company Details
11.4.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Introduction
11.4.4 Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2020-2025)
11.4.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca mRNA Therapy Introduction
11.5.4 Astrazeneca Revenue in mRNA Therapy Business (2020-2025)
11.5.5 Astrazeneca Recent Development
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac mRNA Therapy Introduction
11.6.4 CureVac Revenue in mRNA Therapy Business (2020-2025)
11.6.5 CureVac Recent Development
11.7 Translate Bio
11.7.1 Translate Bio Company Details
11.7.2 Translate Bio Business Overview
11.7.3 Translate Bio mRNA Therapy Introduction
11.7.4 Translate Bio Revenue in mRNA Therapy Business (2020-2025)
11.7.5 Translate Bio Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals mRNA Therapy Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2020-2025)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Arcturus Therapeutics
11.9.1 Arcturus Therapeutics Company Details
11.9.2 Arcturus Therapeutics Business Overview
11.9.3 Arcturus Therapeutics mRNA Therapy Introduction
11.9.4 Arcturus Therapeutics Revenue in mRNA Therapy Business (2020-2025)
11.9.5 Arcturus Therapeutics Recent Development
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Details
11.10.2 Takeda Pharmaceutical Company Business Overview
11.10.3 Takeda Pharmaceutical Company mRNA Therapy Introduction
11.10.4 Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2020-2025)
11.10.5 Takeda Pharmaceutical Company Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis mRNA Therapy Introduction
11.11.4 Novartis Revenue in mRNA Therapy Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi mRNA Therapy Introduction
11.12.4 Sanofi Revenue in mRNA Therapy Business (2020-2025)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 mRNA Targeted Delivery in vivo
1.3.3 Genetically Modified T cells
1.3.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
1.3.5 Small Molecule Drugs Discovery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Therapy Market Perspective (2020-2031)
2.2 Global mRNA Therapy Growth Trends by Region
2.2.1 Global mRNA Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 mRNA Therapy Historic Market Size by Region (2020-2025)
2.2.3 mRNA Therapy Forecasted Market Size by Region (2026-2031)
2.3 mRNA Therapy Market Dynamics
2.3.1 mRNA Therapy Industry Trends
2.3.2 mRNA Therapy Market Drivers
2.3.3 mRNA Therapy Market Challenges
2.3.4 mRNA Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Therapy Players by Revenue
3.1.1 Global Top mRNA Therapy Players by Revenue (2020-2025)
3.1.2 Global mRNA Therapy Revenue Market Share by Players (2020-2025)
3.2 Global mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Therapy Revenue
3.4 Global mRNA Therapy Market Concentration Ratio
3.4.1 Global mRNA Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Therapy Revenue in 2024
3.5 Global Key Players of mRNA Therapy Head office and Area Served
3.6 Global Key Players of mRNA Therapy, Product and Application
3.7 Global Key Players of mRNA Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Therapy Breakdown Data by Type
4.1 Global mRNA Therapy Historic Market Size by Type (2020-2025)
4.2 Global mRNA Therapy Forecasted Market Size by Type (2026-2031)
5 mRNA Therapy Breakdown Data by Application
5.1 Global mRNA Therapy Historic Market Size by Application (2020-2025)
5.2 Global mRNA Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America mRNA Therapy Market Size (2020-2031)
6.2 North America mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America mRNA Therapy Market Size by Country (2020-2025)
6.4 North America mRNA Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Therapy Market Size (2020-2031)
7.2 Europe mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe mRNA Therapy Market Size by Country (2020-2025)
7.4 Europe mRNA Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Therapy Market Size (2020-2031)
8.2 Asia-Pacific mRNA Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific mRNA Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific mRNA Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Therapy Market Size (2020-2031)
9.2 Latin America mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America mRNA Therapy Market Size by Country (2020-2025)
9.4 Latin America mRNA Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Therapy Market Size (2020-2031)
10.2 Middle East & Africa mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa mRNA Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa mRNA Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Details
11.1.2 Moderna Business Overview
11.1.3 Moderna mRNA Therapy Introduction
11.1.4 Moderna Revenue in mRNA Therapy Business (2020-2025)
11.1.5 Moderna Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech mRNA Therapy Introduction
11.2.4 BioNTech Revenue in mRNA Therapy Business (2020-2025)
11.2.5 BioNTech Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer mRNA Therapy Introduction
11.3.4 Pfizer Revenue in mRNA Therapy Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Arcturus Therapeutics Holdings Inc.
11.4.1 Arcturus Therapeutics Holdings Inc. Company Details
11.4.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Introduction
11.4.4 Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2020-2025)
11.4.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca mRNA Therapy Introduction
11.5.4 Astrazeneca Revenue in mRNA Therapy Business (2020-2025)
11.5.5 Astrazeneca Recent Development
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac mRNA Therapy Introduction
11.6.4 CureVac Revenue in mRNA Therapy Business (2020-2025)
11.6.5 CureVac Recent Development
11.7 Translate Bio
11.7.1 Translate Bio Company Details
11.7.2 Translate Bio Business Overview
11.7.3 Translate Bio mRNA Therapy Introduction
11.7.4 Translate Bio Revenue in mRNA Therapy Business (2020-2025)
11.7.5 Translate Bio Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals mRNA Therapy Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2020-2025)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Arcturus Therapeutics
11.9.1 Arcturus Therapeutics Company Details
11.9.2 Arcturus Therapeutics Business Overview
11.9.3 Arcturus Therapeutics mRNA Therapy Introduction
11.9.4 Arcturus Therapeutics Revenue in mRNA Therapy Business (2020-2025)
11.9.5 Arcturus Therapeutics Recent Development
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Details
11.10.2 Takeda Pharmaceutical Company Business Overview
11.10.3 Takeda Pharmaceutical Company mRNA Therapy Introduction
11.10.4 Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2020-2025)
11.10.5 Takeda Pharmaceutical Company Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis mRNA Therapy Introduction
11.11.4 Novartis Revenue in mRNA Therapy Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi mRNA Therapy Introduction
11.12.4 Sanofi Revenue in mRNA Therapy Business (2020-2025)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global mRNA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global mRNA Therapy Market Share by Region (2020-2025)
Table 8. Global mRNA Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global mRNA Therapy Market Share by Region (2026-2031)
Table 10. mRNA Therapy Market Trends
Table 11. mRNA Therapy Market Drivers
Table 12. mRNA Therapy Market Challenges
Table 13. mRNA Therapy Market Restraints
Table 14. Global mRNA Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global mRNA Therapy Market Share by Players (2020-2025)
Table 16. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2024)
Table 17. Ranking of Global Top mRNA Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by mRNA Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of mRNA Therapy, Headquarters and Area Served
Table 20. Global Key Players of mRNA Therapy, Product and Application
Table 21. Global Key Players of mRNA Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global mRNA Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global mRNA Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global mRNA Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global mRNA Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global mRNA Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global mRNA Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global mRNA Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific mRNA Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Moderna Company Details
Table 47. Moderna Business Overview
Table 48. Moderna mRNA Therapy Product
Table 49. Moderna Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 50. Moderna Recent Development
Table 51. BioNTech Company Details
Table 52. BioNTech Business Overview
Table 53. BioNTech mRNA Therapy Product
Table 54. BioNTech Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 55. BioNTech Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer mRNA Therapy Product
Table 59. Pfizer Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Arcturus Therapeutics Holdings Inc. Company Details
Table 62. Arcturus Therapeutics Holdings Inc. Business Overview
Table 63. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product
Table 64. Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 65. Arcturus Therapeutics Holdings Inc. Recent Development
Table 66. Astrazeneca Company Details
Table 67. Astrazeneca Business Overview
Table 68. Astrazeneca mRNA Therapy Product
Table 69. Astrazeneca Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 70. Astrazeneca Recent Development
Table 71. CureVac Company Details
Table 72. CureVac Business Overview
Table 73. CureVac mRNA Therapy Product
Table 74. CureVac Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 75. CureVac Recent Development
Table 76. Translate Bio Company Details
Table 77. Translate Bio Business Overview
Table 78. Translate Bio mRNA Therapy Product
Table 79. Translate Bio Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 80. Translate Bio Recent Development
Table 81. Regeneron Pharmaceuticals Company Details
Table 82. Regeneron Pharmaceuticals Business Overview
Table 83. Regeneron Pharmaceuticals mRNA Therapy Product
Table 84. Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Recent Development
Table 86. Arcturus Therapeutics Company Details
Table 87. Arcturus Therapeutics Business Overview
Table 88. Arcturus Therapeutics mRNA Therapy Product
Table 89. Arcturus Therapeutics Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 90. Arcturus Therapeutics Recent Development
Table 91. Takeda Pharmaceutical Company Company Details
Table 92. Takeda Pharmaceutical Company Business Overview
Table 93. Takeda Pharmaceutical Company mRNA Therapy Product
Table 94. Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 95. Takeda Pharmaceutical Company Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis mRNA Therapy Product
Table 99. Novartis Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi mRNA Therapy Product
Table 104. Sanofi Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. mRNA Therapy Picture
Figure 2. Global mRNA Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global mRNA Therapy Market Share by Type: 2024 VS 2031
Figure 4. Vaccine Features
Figure 5. Drugs Features
Figure 6. Global mRNA Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global mRNA Therapy Market Share by Application: 2024 VS 2031
Figure 8. mRNA Targeted Delivery in vivo Case Studies
Figure 9. Genetically Modified T cells Case Studies
Figure 10. Transforming Nanoparticles to Develop Immunotherapy for Cancer Case Studies
Figure 11. Small Molecule Drugs Discovery Case Studies
Figure 12. mRNA Therapy Report Years Considered
Figure 13. Global mRNA Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global mRNA Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global mRNA Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global mRNA Therapy Market Share by Players in 2024
Figure 17. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by mRNA Therapy Revenue in 2024
Figure 19. North America mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America mRNA Therapy Market Share by Country (2020-2031)
Figure 21. United States mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe mRNA Therapy Market Share by Country (2020-2031)
Figure 25. Germany mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific mRNA Therapy Market Share by Region (2020-2031)
Figure 33. China mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America mRNA Therapy Market Share by Country (2020-2031)
Figure 41. Mexico mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa mRNA Therapy Market Share by Country (2020-2031)
Figure 45. Turkey mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Moderna Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 49. BioNTech Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 51. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 52. Astrazeneca Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 53. CureVac Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 54. Translate Bio Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 56. Arcturus Therapeutics Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 57. Takeda Pharmaceutical Company Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global mRNA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global mRNA Therapy Market Share by Region (2020-2025)
Table 8. Global mRNA Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global mRNA Therapy Market Share by Region (2026-2031)
Table 10. mRNA Therapy Market Trends
Table 11. mRNA Therapy Market Drivers
Table 12. mRNA Therapy Market Challenges
Table 13. mRNA Therapy Market Restraints
Table 14. Global mRNA Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global mRNA Therapy Market Share by Players (2020-2025)
Table 16. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2024)
Table 17. Ranking of Global Top mRNA Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by mRNA Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of mRNA Therapy, Headquarters and Area Served
Table 20. Global Key Players of mRNA Therapy, Product and Application
Table 21. Global Key Players of mRNA Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global mRNA Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global mRNA Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global mRNA Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global mRNA Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global mRNA Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global mRNA Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global mRNA Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific mRNA Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Moderna Company Details
Table 47. Moderna Business Overview
Table 48. Moderna mRNA Therapy Product
Table 49. Moderna Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 50. Moderna Recent Development
Table 51. BioNTech Company Details
Table 52. BioNTech Business Overview
Table 53. BioNTech mRNA Therapy Product
Table 54. BioNTech Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 55. BioNTech Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer mRNA Therapy Product
Table 59. Pfizer Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Arcturus Therapeutics Holdings Inc. Company Details
Table 62. Arcturus Therapeutics Holdings Inc. Business Overview
Table 63. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product
Table 64. Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 65. Arcturus Therapeutics Holdings Inc. Recent Development
Table 66. Astrazeneca Company Details
Table 67. Astrazeneca Business Overview
Table 68. Astrazeneca mRNA Therapy Product
Table 69. Astrazeneca Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 70. Astrazeneca Recent Development
Table 71. CureVac Company Details
Table 72. CureVac Business Overview
Table 73. CureVac mRNA Therapy Product
Table 74. CureVac Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 75. CureVac Recent Development
Table 76. Translate Bio Company Details
Table 77. Translate Bio Business Overview
Table 78. Translate Bio mRNA Therapy Product
Table 79. Translate Bio Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 80. Translate Bio Recent Development
Table 81. Regeneron Pharmaceuticals Company Details
Table 82. Regeneron Pharmaceuticals Business Overview
Table 83. Regeneron Pharmaceuticals mRNA Therapy Product
Table 84. Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Recent Development
Table 86. Arcturus Therapeutics Company Details
Table 87. Arcturus Therapeutics Business Overview
Table 88. Arcturus Therapeutics mRNA Therapy Product
Table 89. Arcturus Therapeutics Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 90. Arcturus Therapeutics Recent Development
Table 91. Takeda Pharmaceutical Company Company Details
Table 92. Takeda Pharmaceutical Company Business Overview
Table 93. Takeda Pharmaceutical Company mRNA Therapy Product
Table 94. Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 95. Takeda Pharmaceutical Company Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis mRNA Therapy Product
Table 99. Novartis Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi mRNA Therapy Product
Table 104. Sanofi Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. mRNA Therapy Picture
Figure 2. Global mRNA Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global mRNA Therapy Market Share by Type: 2024 VS 2031
Figure 4. Vaccine Features
Figure 5. Drugs Features
Figure 6. Global mRNA Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global mRNA Therapy Market Share by Application: 2024 VS 2031
Figure 8. mRNA Targeted Delivery in vivo Case Studies
Figure 9. Genetically Modified T cells Case Studies
Figure 10. Transforming Nanoparticles to Develop Immunotherapy for Cancer Case Studies
Figure 11. Small Molecule Drugs Discovery Case Studies
Figure 12. mRNA Therapy Report Years Considered
Figure 13. Global mRNA Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global mRNA Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global mRNA Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global mRNA Therapy Market Share by Players in 2024
Figure 17. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by mRNA Therapy Revenue in 2024
Figure 19. North America mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America mRNA Therapy Market Share by Country (2020-2031)
Figure 21. United States mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe mRNA Therapy Market Share by Country (2020-2031)
Figure 25. Germany mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific mRNA Therapy Market Share by Region (2020-2031)
Figure 33. China mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America mRNA Therapy Market Share by Country (2020-2031)
Figure 41. Mexico mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa mRNA Therapy Market Share by Country (2020-2031)
Figure 45. Turkey mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Moderna Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 49. BioNTech Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 51. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 52. Astrazeneca Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 53. CureVac Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 54. Translate Bio Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 56. Arcturus Therapeutics Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 57. Takeda Pharmaceutical Company Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in mRNA Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232